Integrin αvβ3-targeted gold nanoshells augment tumor vasculature-specific imaging and therapy
Open Access
- 1 January 2011
- journal article
- research article
- Published by Taylor & Francis Ltd in International Journal of Nanomedicine
- Vol. 6, 259-269
- https://doi.org/10.2147/ijn.s15479
Abstract
Purpose: Gold nanoshells (NSs) have already shown great promise as photothermal actuators for cancer therapy. Integrin αvβ3 is a marker that is specifically and preferentially overexpressed on multiple tumor types and on angiogenic tumor neovasculature. Active targeting of NSs to integrin αvβ3 offers the potential to increase accumulation preferentially in tumors and thereby enhance therapy efficacy. Methods: Enzyme-linked immunosorbent assay (ELISA) and cell binding assay were used to study the in vitro binding affinities of the targeted nanoconjugate NS–RGDfK. In vivo biodistribution and tumor specificity were analyzed using 64Cu-radiolabeled untargeted and targeted NSs in live nude rats bearing head and neck squamous cell carcinoma (HNSCC) xenografts. The potential thermal therapy applications of NS–RGDfK were evaluated by subablative thermal therapy of tumor xenografts using untargeted and targeted NSs. Results: ELISA and cell binding assay confirmed the binding affinity of NS–RGDfK to integrin αvβ3. Positron emission tomography/computed tomography imaging suggested that tumor targeting is improved by conjugation of NSs to cyclo(RGDfK) and peaks at ~20 hours postinjection. In the subablative thermal therapy study, greater biological effectiveness of targeted NSs was implied by the greater degree of tumor necrosis. Conclusion: The results presented in this paper set the stage for the advancement of integrin αvβ3-targeted NSs as therapeutic nanoconstructs for effective cancer therapy.Keywords
This publication has 33 references indexed in Scilit:
- A novel αvβ3-blocking disintegrin containing the RGD motive, DisBa-01, inhibits bFGF-induced angiogenesis and melanoma metastasisClinical & Experimental Metastasis, 2007
- Synthesis, in vitro, and in vivo characterization of an integrin αvβ3-targeted molecular probe for optical imaging of tumorBioorganic & Medicinal Chemistry, 2005
- In vivo Near-Infrared Fluorescence Imaging of Integrin αvβ3 in Brain Tumor XenograftsCancer Research, 2004
- Detection of Injury-Induced Vascular Remodeling by Targeting Activated α v β 3 Integrin In VivoCirculation, 2004
- Cellular Trajectories of Peptide-Modified Gold Particle Complexes: Comparison of Nuclear Localization Signals and Peptide Transduction DomainsBioconjugate Chemistry, 2004
- Ultrasonic Analysis of Peptide- and Antibody-Targeted Microbubble Contrast Agents for Molecular Imaging of αvβ3-Expressing CellsMolecular Imaging, 2004
- Nonpeptide αvβ3 Antagonists. 8. In Vitro and in Vivo Evaluation of a Potent αvβ3 Antagonist for the Prevention and Treatment of OsteoporosisJournal of Medicinal Chemistry, 2003
- Imaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to α v β 3Circulation, 2003
- Crystal Structure of the Extracellular Segment of Integrin αVβ3Science, 2001
- An Allosteric Ca2+ Binding Site on the β3-Integrins That Regulates the Dissociation Rate for RGD LigandsOnline Journal of Public Health Informatics, 1996